Homodimerization as a molecular switch between low and high efficiency PrP^C cell surface delivery and neuroprotective activity

References

• Bendheim PE, Bolton DC. A 54-kDa normal cellular protein may be the precursor of the scrapie agent protease-resistant protein. Proc Natl Acad Sci U S A 1986; 83:2214 - 8; http://dx.doi.org/10.1073/pnas.83.7.2214; PMID: 2421288
   PubMed Web of Science ®Google Scholar
• Meyer RK, Lustig A, Oesch B, Fatzer R, Zurbriggen A, Vandevelde M. A monomer-dimer equilibrium of a cellular prion protein (PrPC) not observed with recombinant PrP. J Biol Chem 2000; 275:38081 - 7; http://dx.doi.org/10.1074/jbc.M007114200; PMID: 10967124
   PubMed Web of Science ®Google Scholar
• Sklaviadis TK, Manuelidis L, Manuelidis EE. Physical properties of the Creutzfeldt-Jakob disease agent. J Virol 1989; 63:1212 - 22; PMID: 2492609
   PubMed Web of Science ®Google Scholar
• Priola SA, Caughey B, Wehrly K, Chesebro B. A 60-kDa prion protein (PrP) with properties of both the normal and scrapie-associated forms of PrP. J Biol Chem 1995; 270:3299 - 305; http://dx.doi.org/10.1074/jbc.270.7.3299; PMID: 7852415
   PubMed Web of Science ®Google Scholar
• Rambold AS, Müller V, Ron U, Ben-Tal N, Winklhofer KF, Tatzelt J. Stress-protective signalling of prion protein is corrupted by scrapie prions. EMBO J 2008; 27:1974 - 84; http://dx.doi.org/10.1038/emboj.2008.122; PMID: 18566584
   PubMed Web of Science ®Google Scholar
• Warwicker J. Modeling a prion protein dimer: predictions for fibril formation. Biochem Biophys Res Commun 2000; 278:646 - 52; http://dx.doi.org/10.1006/bbrc.2000.3829; PMID: 11095963
   PubMed Web of Science ®Google Scholar
• Tompa P, Tusnády GE, Friedrich P, Simon I. The role of dimerization in prion replication. Biophys J 2002; 82:1711 - 8; http://dx.doi.org/10.1016/S0006-3495(02)75523-9; PMID: 11916832
   PubMed Web of Science ®Google Scholar
• Stöhr J, Weinmann N, Wille H, Kaimann T, Nagel-Steger L, Birkmann E, et al. Mechanisms of prion protein assembly into amyloid. Proc Natl Acad Sci U S A 2008; 105:2409 - 14; http://dx.doi.org/10.1073/pnas.0712036105; PMID: 18268326
   PubMed Web of Science ®Google Scholar
• Jansen K, Schäfer O, Birkmann E, Post K, Serban H, Prusiner SB, et al. Structural intermediates in the putative pathway from the cellular prion protein to the pathogenic form. Biol Chem 2001; 382:683 - 91; http://dx.doi.org/10.1515/BC.2001.081; PMID: 11405232
   PubMed Web of Science ®Google Scholar
• Goggin K, Bissonnette C, Grenier C, Volkov L, Roucou X. Aggregation of cellular prion protein is initiated by proximity-induced dimerization. J Neurochem 2007; 102:1195 - 205; http://dx.doi.org/10.1111/j.1471-4159.2007.04611.x; PMID: 17663754
   PubMed Web of Science ®Google Scholar
• Solforosi L, Criado JR, McGavern DB, Wirz S, Sánchez-Alavez M, Sugama S, et al. Cross-linking cellular prion protein triggers neuronal apoptosis in vivo. Science 2004; 303:1514 - 6; http://dx.doi.org/10.1126/science.1094273; PMID: 14752167
   PubMed Web of Science ®Google Scholar
• Li L, Napper S, Cashman NR. Immunotherapy for prion diseases: opportunities and obstacles. Immunotherapy 2010; 2:269 - 82; http://dx.doi.org/10.2217/imt.10.3; PMID: 20635933
   PubMed Web of Science ®Google Scholar
• Klöhn PC, Farmer M, Linehan JM, O’Malley C, Fernandez de Marco M, Taylor W, et al. PrP antibodies do not trigger mouse hippocampal neuron apoptosis. Science 2012; 335:52; http://dx.doi.org/10.1126/science.1215579; PMID: 22223800
   PubMed Web of Science ®Google Scholar
• Aguzzi A, O’Connor T. Protein aggregation diseases: pathogenicity and therapeutic perspectives. Nat Rev Drug Discov 2010; 9:237 - 48; http://dx.doi.org/10.1038/nrd3050; PMID: 20190788
   PubMed Web of Science ®Google Scholar
• Béland M, Motard J, Barbarin A, Roucou X. PrP(C) homodimerization stimulates the production of PrPC cleaved fragments PrPN1 and PrPC1. J Neurosci 2012; 32:13255 - 63; http://dx.doi.org/10.1523/JNEUROSCI.2236-12.2012; PMID: 22993441
   PubMed Web of Science ®Google Scholar
• Westergard L, Turnbaugh JA, Harris DA. A naturally occurring C-terminal fragment of the prion protein (PrP) delays disease and acts as a dominant-negative inhibitor of PrPSc formation. J Biol Chem 2011; 286:44234 - 42; http://dx.doi.org/10.1074/jbc.M111.286195; PMID: 22025612
   PubMed Web of Science ®Google Scholar
• Meier P, Genoud N, Prinz M, Maissen M, Rülicke T, Zurbriggen A, et al. Soluble dimeric prion protein binds PrP(Sc) in vivo and antagonizes prion disease. Cell 2003; 113:49 - 60; http://dx.doi.org/10.1016/S0092-8674(03)00201-0; PMID: 12679034
   PubMed Web of Science ®Google Scholar
• Winklhofer KF, Heske J, Heller U, Reintjes A, Muranyi W, Moarefi I, et al. Determinants of the in vivo folding of the prion protein. A bipartite function of helix 1 in folding and aggregation. J Biol Chem 2003; 278:14961 - 70; http://dx.doi.org/10.1074/jbc.M209942200; PMID: 12556465
   PubMed Web of Science ®Google Scholar
• Rane NS, Yonkovich JL, Hegde RS. Protection from cytosolic prion protein toxicity by modulation of protein translocation. EMBO J 2004; 23:4550 - 9; http://dx.doi.org/10.1038/sj.emboj.7600462; PMID: 15526034
   PubMed Web of Science ®Google Scholar
• Rane NS, Kang SW, Chakrabarti O, Feigenbaum L, Hegde RS. Reduced translocation of nascent prion protein during ER stress contributes to neurodegeneration. Dev Cell 2008; 15:359 - 70; http://dx.doi.org/10.1016/j.devcel.2008.06.015; PMID: 18804434
   PubMed Web of Science ®Google Scholar
• Rane NS, Chakrabarti O, Feigenbaum L, Hegde RS. Signal sequence insufficiency contributes to neurodegeneration caused by transmembrane prion protein. J Cell Biol 2010; 188:515 - 26; http://dx.doi.org/10.1083/jcb.200911115; PMID: 20156965
   PubMed Web of Science ®Google Scholar
• Ma J, Wollmann R, Lindquist S. Neurotoxicity and neurodegeneration when PrP accumulates in the cytosol. Science 2002; 298:1781 - 5; http://dx.doi.org/10.1126/science.1073725; PMID: 12386337
   PubMed Web of Science ®Google Scholar
• Ashok A, Hegde RS. Selective processing and metabolism of disease-causing mutant prion proteins. PLoS Pathog 2009; 5:e1000479; http://dx.doi.org/10.1371/journal.ppat.1000479; PMID: 19543376
   PubMed Web of Science ®Google Scholar
• Beland M, Roucou X. The prion protein unstructured N-terminal region is a broad-spectrum molecular sensor with diverse and contrasting potential functions. J Neurochem 2012; 120:853-68; PMID: 22145935; DOI: 10.1111/j.1471-4159.2011.07613.x; 10.1111/j.1471-4159.2011.07613.x.
   Google Scholar
• Angers S, Salahpour A, Bouvier M. Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function. Annu Rev Pharmacol Toxicol 2002; 42:409 - 35; http://dx.doi.org/10.1146/annurev.pharmtox.42.091701.082314; PMID: 11807178
   PubMed Web of Science ®Google Scholar
• Terrillon S, Bouvier M. Roles of G-protein-coupled receptor dimerization. EMBO Rep 2004; 5:30 - 4; http://dx.doi.org/10.1038/sj.embor.7400052; PMID: 14710183
   PubMed Web of Science ®Google Scholar
• Milligan G. The role of dimerisation in the cellular trafficking of G-protein-coupled receptors. Curr Opin Pharmacol 2010; 10:23 - 9; http://dx.doi.org/10.1016/j.coph.2009.09.010; PMID: 19850521
   PubMed Web of Science ®Google Scholar
• Kobayashi H, Ogawa K, Yao R, Lichtarge O, Bouvier M. Functional rescue of beta-adrenoceptor dimerization and trafficking by pharmacological chaperones. Traffic 2009; 10:1019-33; PMID: 19515093; DOI: 10.1111/j.1600-0854.2009.00932.x; 10.1111/j.1600-0854.2009.00932.x.
   Google Scholar
• Williams D, Devi LA. Escorts take the lead molecular chaperones as therapeutic targets. Prog Mol Biol Transl Sci 2010; 91:121 - 49; http://dx.doi.org/10.1016/S1877-1173(10)91005-3; PMID: 20691961
   PubMed Web of Science ®Google Scholar
• Yedidia Y, Horonchik L, Tzaban S, Yanai A, Taraboulos A. Proteasomes and ubiquitin are involved in the turnover of the wild-type prion protein. EMBO J 2001; 20:5383 - 91; http://dx.doi.org/10.1093/emboj/20.19.5383; PMID: 11574470
   PubMed Web of Science ®Google Scholar
• Stewart RS, Piccardo P, Ghetti B, Harris DA. Neurodegenerative illness in transgenic mice expressing a transmembrane form of the prion protein. J Neurosci 2005; 25:3469 - 77; http://dx.doi.org/10.1523/JNEUROSCI.0105-05.2005; PMID: 15800202
   PubMed Web of Science ®Google Scholar
• Hegde RS, Mastrianni JA, Scott MR, DeFea KA, Tremblay P, Torchia M, et al. A transmembrane form of the prion protein in neurodegenerative disease. Science 1998; 279:827 - 34; http://dx.doi.org/10.1126/science.279.5352.827; PMID: 9452375
   PubMed Web of Science ®Google Scholar
• Hegde RS, Tremblay P, Groth D, DeArmond SJ, Prusiner SB, Lingappa VR. Transmissible and genetic prion diseases share a common pathway of neurodegeneration. Nature 1999; 402:822 - 6; http://dx.doi.org/10.1038/45574; PMID: 10617204
   PubMed Web of Science ®Google Scholar
• Chakrabarti O, Ashok A, Hegde RS. Prion protein biosynthesis and its emerging role in neurodegeneration. Trends Biochem Sci 2009; 34:287 - 95; http://dx.doi.org/10.1016/j.tibs.2009.03.001; PMID: 19447626
   PubMed Web of Science ®Google Scholar
• Wik L, Klingeborn M, Willander H, Linne T. Separate mechanisms act concurrently to shed and release the prion protein from the cell. Prion 2012; 6:498-509; PMID: 23093798; DOI: 10.4161/pri.22588; 10.4161/pri.22588.
   Google Scholar
• Oliveira-Martins JB, Yusa S, Calella AM, Bridel C, Baumann F, Dametto P, et al. Unexpected tolerance of alpha-cleavage of the prion protein to sequence variations. PLoS One 2010; 5:e9107; http://dx.doi.org/10.1371/journal.pone.0009107; PMID: 20161712
   PubMed Web of Science ®Google Scholar
• Bremer J, Baumann F, Tiberi C, Wessig C, Fischer H, Schwarz P, et al. Axonal prion protein is required for peripheral myelin maintenance. Nat Neurosci 2010; 13:310 - 8; http://dx.doi.org/10.1038/nn.2483; PMID: 20098419
   PubMed Web of Science ®Google Scholar
• Walmsley AR, Watt NT, Taylor DR, Perera WS, Hooper NM. alpha-cleavage of the prion protein occurs in a late compartment of the secretory pathway and is independent of lipid rafts. Mol Cell Neurosci 2009; 40:242 - 8; http://dx.doi.org/10.1016/j.mcn.2008.10.012; PMID: 19056496
   PubMed Web of Science ®Google Scholar
• Resenberger UK, Harmeier A, Woerner AC, Goodman JL, Müller V, Krishnan R, et al. The cellular prion protein mediates neurotoxic signalling of β-sheet-rich conformers independent of prion replication. EMBO J 2011; 30:2057 - 70; http://dx.doi.org/10.1038/emboj.2011.86; PMID: 21441896
   PubMed Web of Science ®Google Scholar
• Guillot-Sestier MV, Sunyach C, Ferreira ST, Marzolo MP, Bauer C, Thevenet A, et al. α-Secretase-derived fragment of cellular prion, N1, protects against monomeric and oligomeric amyloid β (Aβ)-associated cell death. J Biol Chem 2012; 287:5021 - 32; http://dx.doi.org/10.1074/jbc.M111.323626; PMID: 22184125
   PubMed Web of Science ®Google Scholar
• Turnbaugh JA, Unterberger U, Saá P, Massignan T, Fluharty BR, Bowman FP, et al. The N-terminal, polybasic region of PrP(C) dictates the efficiency of prion propagation by binding to PrP(Sc). J Neurosci 2012; 32:8817 - 30; http://dx.doi.org/10.1523/JNEUROSCI.1103-12.2012; PMID: 22745483
   PubMed Web of Science ®Google Scholar
• Lo RY, Shyu WC, Lin SZ, Wang HJ, Chen SS, Li H. New molecular insights into cellular survival and stress responses: neuroprotective role of cellular prion protein (PrPC). Mol Neurobiol 2007; 35:236 - 44; http://dx.doi.org/10.1007/s12035-007-8003-y; PMID: 17917112
   PubMed Web of Science ®Google Scholar
• Roucou X, Giannopoulos PN, Zhang Y, Jodoin J, Goodyer CG, LeBlanc A. Cellular prion protein inhibits proapoptotic Bax conformational change in human neurons and in breast carcinoma MCF-7 cells. Cell Death Differ 2005; 12:783 - 95; http://dx.doi.org/10.1038/sj.cdd.4401629; PMID: 15846375
   PubMed Web of Science ®Google Scholar
• Rial D, Piermartiri TC, Duarte FS, Tasca CI, Walz R, Prediger RD. Overexpression of cellular prion protein (PrP(C)) prevents cognitive dysfunction and apoptotic neuronal cell death induced by amyloid-beta (abeta(1)(-)(4)(0)) administration in mice. Neuroscience 2012; 215:79-89; PMID: 22537845; DOI: 10.1016/j.neuroscience.2012.04.034; 10.1016/j.neuroscience.2012.04.034.
   Google Scholar
• Biasini E, Harris DA. Targeting the cellular prion protein to treat neurodegeneration. Future Med Chem 2012; 4:1655-8; PMID: 22924502; DOI: 10.4155/fmc.12.114; 10.4155/fmc.12.114.
   Google Scholar